The American pharmaceutical company Johnson & Johnson has applied for authorization for its vaccine against Covid-19 in the European Union. The European Medicines Agency (EMA) announced on Tuesday (February 16th) that a decision is expected in March, writes AFP.
This single-injection vaccine would be the fourth approved in the European Union if it receives the green light from the Amsterdam-based Agency. Almost 46,000 people have been vaccinated in the last 24 hours. 99 adverse reactions were reported
"The EMA has received an application for marketing authorization for the Covid-19 vaccine developed by Janssen-Cilag International N.V.," the agency said, referring to Johnson & Johnson's European subsidiary.
European experts "could issue an opinion in mid-March, provided the company's data on the efficacy, safety and quality of the vaccine are sufficiently complete and convincing," according to the EMA.
The Johnson & Johnson vaccine has been undergoing continuous evaluation by the EMA since December 1.How many people became infected with SARS-CoV-2 after the first dose of vaccine. The figure presented by the military The three vaccines authorized so far on the European market are those from AstraZeneca, Pfizer / BioNTech and Moderna.
The European Commission has ordered 200 million doses of Johnson & Johnson vaccine, with an option for an additional 200 million. 100 million doses must be delivered by now by June if the vaccine is authorized.
No comments:
Post a Comment